1.
Am Soc Clin Oncol Educ Book
; 44(3): e431608, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38776509
RESUMO
Lifileucel or TIL has recently been FDA approved for metastatic melanoma patients as first cell therapy for a solid tumor. We discuss roll-out of TIL as new SOC and other upcoming new cell therapies.